Pathological bacterial translocation in liver cirrhosis

Journal of Hepatology

Volumn 60, Issue 1, 2014, Pages 197-209

  Wiest, Reiner ^a   Lawson, Melissa ^b   Geuking, Markus ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bacterial translocation; Gut associated lymphoid tissue; Liver cirrhosis; Microbiome; Mucosa barrier

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; DEFENSIN; IMMUNOGLOBULIN A ANTIBODY; MUCIN; MUCIN 2; REACTIVE OXYGEN METABOLITE; SECRETORY COMPONENT; TOLL LIKE RECEPTOR;

ACUTE ON CHRONIC LIVER FAILURE; ANAEROBIC BACTERIUM; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; BRAIN DISEASE; DENDRITIC CELL; DISEASE SEVERITY; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LIVER CIRRHOSIS; MICROBIOME; MISSENSE MUTATION; MUCUS; NONHUMAN; PATHOGENESIS; PATHOLOGICAL BACTERIAL TRANSLOCATION; PRIORITY JOURNAL; REVIEW; HISTOPATHOLOGY; LIVER DISEASE;

AMP; ANTIGEN-PRESENTING CELL; ANTIMICROBIAL PEPTIDES; APC; BACTERIAL TRANSLOCATION; BDL; BILE DUCT LIGATION; BT; CARBON-TETRACHLORIDE; CCL(4); DC; DENDRITIC CELL; FARNESOID X RECEPTOR; FXR; GALT; GASTROINTESTINAL; GI; GNB; GRAM-NEGATIVE BACTERIA; GUT-ASSOCIATED LYMPHOID TISSUE; HE; HEPATIC ENCEPHALOPATHY; IEL; IFN; IGA; IL; IMMUNOGLOBULIN A; INTEREPITHELIAL LYMPHOCYTE; INTERFERON; INTERLEUKIN; LIPOPOLYSACCHARIDE; LIVER CIRRHOSIS; LPS; MCP-1; MDP; MESENTERIC LMYPH NODES; MICROBIOME; MLCK; MLN; MONOCYTE CHEMOTATIC PROTEIN-1; MUCOSA BARRIER; MURAMYL-DIPEPTIDE; MYOSIN LIGHT CHAIN KINASE; NFKB; NITRIC OXIDE; NO; NOD; NUCLEAR FACTOR KB; NUCLEOTIDE BINDING OLIGOMERISATION DOMAIN 2; PEPTIDOGLYCANS; PGN; REACTIVE OXYGEN SPECIES; ROS; SBP; SDD; SELECTIVE GUT DECONTAMINATION; SIBO; SMALL INTESTINAL BACTERIAL OVERGROWTH; SPONTANEOUS BACTERIAL PERITONITIS; TIGHT JUNCTION; TJ; TLR; TNF; TOLL-LIKE-RECEPTOR; TUMOR NECROSIS FACTOR; ZO; ZONULA OCCLUDENS;

ANIMALS; BACTERIAL TRANSLOCATION; BETA-DEFENSINS; HUMANS; INTESTINES; LIVER CIRRHOSIS; LYMPH NODES; LYMPHOID TISSUE; SEVERITY OF ILLNESS INDEX;

EID: 84890554765     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.07.044     Document Type: Review

References (209)

1. R.D. Berg, and A.W. Garlington Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model Infect Immun 23 1979 403 411
2. D. Benten, and R. Wiest Gut microbiome and intestinal barrier failure-the "Achilles heel" in hepatology? J Hepatol 56 2012 1221 1223
3. Z. Teltschik, R. Wiest, J. Beisner, S. Nuding, C. Hofmann, and J. Schoelmerich Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense Hepatology 55 2012 1154 1163
4. G. Garcia-Tsao, and R. Wiest Gut microflora in the pathogenesis of the complications of cirrhosis Best Pract Res Clin Gastroenterol 18 2004 353 372
5. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2 2001 675 680
6. M. Rescigno, M. Urbano, B. Valzasina, M. Francolini, G. Rotta, and R. Bonasio Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria Nat Immunol 2 2001 361 367
7. K. Hase, K. Kawano, T. Nochi, G.S. Pontes, S. Fukuda, and M. Ebisawa Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response Nature 462 2009 226 230
8. L. Munoz, B.M. Jose, M. Ubeda, M. Lario, D. Diaz, and R. Frances Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis Hepatology 56 2012 1861 1869
9. S. Hapfelmeier, M.A. Lawson, E. Slack, J.K. Kirundi, M. Stoel, and M. Heikenwalder Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses Science 328 2010 1705 1709
10. D. Kirkland, A. Benson, J. Mirpuri, R. Pifer, B. Hou, and A.L. DeFranco B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage Immunity 36 2012 228 238
11. H. Doi, T.K. Iyer, E. Carpenter, H. Li, K.M. Chang, and R.H. Vonderheide Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population Hepatology 55 2012 709 719
12. M.D. Gautreaux, E.A. Deitch, and R.D. Berg T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract Infect Immun 62 1994 2874 2884
13. W.E. Owens, and R.D. Berg Bacterial translocation from the gastrointestinal tract of athymic (nu/nu) mice Infect Immun 27 1980 461 467
14. M.A. Choudhry, N. Fazal, M. Goto, R.L. Gamelli, and M.M. Sayeed Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury Am J Physiol Gastrointest Liver Physiol 282 2002 G937 G947
15. A. MacPherson, D. Gatto, E. Sainsbury, G.R. Harriman, H. Hengartner, and R.M. Zinkernagel A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria Science 288 2000 2222 2226
16. A.J. Macpherson, and T. Uhr Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria Science 303 2004 1662 1665
17. R.D. Berg, E. Wommack, and E.A. Deitch Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation Arch Surg 123 1988 1359 1364
18. A.N. DeMeo, and B.R. Andersen Defective chemotaxis associated with a serum inhibitor in cirrhotic patients N Engl J Med 286 1972 735 740
19. G. Holdstock, B. Leslie, S. Hill, A. Tanner, and R. Wright Monocyte function in cirrhosis J Clin Pathol 35 1982 972 979
20. C. Fiuza, M. Salcedo, G. Clemente, and J.M. Tellado In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease J Infect Dis 182 2000 526 533
21. A. Hassner, Y. Kletter, D. Shlag, M. Yedvab, M. Aronson, and S. Shibolet Impaired monocyte function in liver cirrhosis Br Med J (Clin Res Ed) 282 1981 1262 1263
22. K.L. Propst-Graham, L.C. Preheim, E.A. Vander Top, M.U. Snitily, and M.J. Gentry-Nielsen Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae BMC Microbiol 7 2007 94
23. G. Tritto, Z. Bechlis, V. Stadlbauer, N. Davies, R. Frances, and N. Shah Evidence of neutrophil functional defect despite inflammation in stable cirrhosis J Hepatol 55 2011 574 581
24. F. Trevisani, E. Castelli, F.G. Foschi, M. Parazza, E. Loggi, and M. Bertelli Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome Gut 50 2002 707 712
25. A. Rimola, R. Soto, F. Bory, V. Arroyo, C. Piera, and J. Rodes Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis Hepatology 4 1984 53 58
26. G. Astaldi, and E. Strosselli Peroral biopsy of the intestinal mucosa in hepatic cirrhosis Am J Dig Dis 5 1960 603 612
27. D.A. Norman, J.M. Atkins, L.L. Seelig Jr., C. Gomez-Sanchez, and G.J. Krejs Water and electrolyte movement and mucosal morphology in the jejunum of patients with portal hypertension Gastroenterology 79 1980 707 715
28. V. Misra, S. Misra, M. Dwivedi, and S. Gupta Histomorphometric study of portal hypertensive enteropathy Am J Clin Pathol 108 1997 652 657
29. B. Campillo, P. Pernet, P.N. Bories, J.P. Richardet, M. Devanlay, and C. Aussel Intestinal permeability in liver cirrhosis: relationship with severe septic complications Eur J Gastroenterol Hepatol 11 1999 755 759
30. G. Ersoz, A. Aydin, S. Erdem, D. Yuksel, U. Akarca, and K. Kumanlioglu Intestinal permeability in liver cirrhosis Eur J Gastroenterol Hepatol 11 1999 409 412
31. S. Pascual, J. Such, A. Esteban, P. Zapater, J.A. Casellas, and J.R. Aparicio Intestinal permeability is increased in patients with advanced cirrhosis Hepatogastroenterology 50 2003 1482 1486
32. M.J. Zuckerman, I.S. Menzies, H. Ho, G.G. Gregory, N.A. Casner, and R.S. Crane Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes Dig Dis Sci 49 2004 621 626
33. K. Norman, M. Pirlich, J.D. Schulzke, C. Smoliner, H. Lochs, and L. Valentini Increased intestinal permeability in malnourished patients with liver cirrhosis Eur J Clin Nutr 66 2012 1116 1119
34. T. Reiberger, A. Ferlitsch, B.A. Payer, M. Mandorfer, B.B. Heinisch, and H. Hayden Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis J Hepatol 58 2013 911 921
35. A.M. Marchiando, W.V. Graham, and J.R. Turner Epithelial barriers in homeostasis and disease Annu Rev Pathol 5 2010 119 144
36. P. Hartmann, M. Haimerl, M. Mazagova, D.A. Brenner, and B. Schnabl Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice Gastroenterology 143 2012 1330 1340
37. S.F. Assimakopoulos, A.C. Tsamandas, G.I. Tsiaoussis, E. Karatza, C. Triantos, and C.E. Vagianos Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability Eur J Clin Invest 42 2012 439 446
38. C. Macutkiewicz, G. Carlson, E. Clark, U. Dobrindt, I. Roberts, and G. Warhurst Characterisation of Escherichia coli strains involved in transcytosis across gut epithelial cells exposed to metabolic and inflammatory stress Microbes Infect 10 2008 424 431
39. K. Lewis, F. Lutgendorff, V. Phan, J.D. Soderholm, P.M. Sherman, and D.M. McKay Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate Inflamm Bowel Dis 16 2010 1138 1148
40. Y.R. Mahida, and S. Johal NF-kB may determine whether epithelial cell-microbial interactions in the intestine are hostile or friendly Clin Exp Immunol 123 2001 347 349
41. T. Shimizu, T. Tani, K. Hanasawa, Y. Endo, and M. Kodama The role of bacterial translocation on neutrophil activation during hemorrhagic shock in rats Shock 16 2001 59 63
42. J.C. Kalff, N.T. Schwarz, K.J. Walgenbach, W.H. Schraut, and A.J. Bauer Leukocytes of the intestinal muscularis: their phenotype and isolation J Leukoc Biol 63 1998 683 691
43. G. Garcia-Tsao, F.Y. Lee, G.E. Barden, R. Cartun, and A.B. West Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites Gastroenterology 108 1995 1835 1841
44. A.S. Nagral, A.S. Joshi, S.J. Bhatia, P. Abraham, F.P. Mistry, and I.M. Vora Congestive jejunopathy in portal hypertension Gut 34 1993 694 697
45. O. Saitoh, K. Sugi, K. Lojima, H. Matsumoto, K. Nakagawa, and M. Kayazawa Increased prevalence of intestinal inflammation in patients with liver cirrhosis World J Gastroenterol 5 1999 391 396
46. F. Gundling, F. Schmidtler, A. Hapfelmeier, B. Schulte, T. Schmidt, and C. Pehl Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis Liver Int 31 2011 1406 1415
47. H. Poehlmann, J.C. Schefold, H. Zuckermann-Becker, H.D. Volk, and C. Meisel Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis Crit Care 13 2009 R119
48. H.E. Wasmuth, D. Kunz, E. Yagmur, A. Timmer-Stranghoner, D. Vidacek, and E. Siewert Patients with acute on chronic liver failure display "sepsis-like" immune paralysis J Hepatol 42 2005 195 201
49. S. Vaishnava, C.L. Behrendt, A.S. Ismail, L. Eckmann, and L.V. Hooper Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface Proc Natl Acad Sci U S A 105 2008 20858 20863
50. T. Ayabe, D.P. Satchell, C.L. Wilson, W.C. Parks, M.E. Selsted, and A.J. Ouellette Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria Nat Immunol 1 2000 113 118
51. C.K. Ogle, J.G. Noel, X. Guo, D.A. Wells, J.F. Valente, and J.D. Ogle The ability of endotoxin-stimulated enterocytes to produce bactericidal factors Crit Care Med 30 2002 428 434
52. B.O. Schroeder, Z. Wu, S. Nuding, S. Groscurth, M. Marcinowski, and J. Beisner Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1 Nature 469 2011 419 423
53. A.W. Yan, D.E. Fouts, J. Brandl, P. Starkel, M. Torralba, and E. Schott Enteric dysbiosis associated with a mouse model of alcoholic liver disease Hepatology 53 2011 96 105
54. H.L. Cash, C.V. Whitham, C.L. Behrendt, and L.V. Hooper Symbiotic bacteria direct expression of an intestinal bactericidal lectin Science 313 2006 1126 1130
55. S. Mukherjee, C.L. Partch, R.E. Lehotzky, C.V. Whitham, H. Chu, and C.L. Bevins Regulation of C-type lectin antimicrobial activity by a flexible N-terminal prosegment J Biol Chem 284 2009 4881 4888
56. J.S. Aranow, and M.P. Fink Determinants of intestinal barrier failure in critical illness Br J Anaesth 77 1996 71 81
57. Y.S. Kim, and S.B. Ho Intestinal goblet cells and mucins in health and disease: recent insights and progress Curr Gastroenterol Rep 12 2010 319 330
58. U. Meyer-Hoffert, M.W. Hornef, B. Henriques-Normark, L.G. Axelsson, T. Midtvedt, and K. Putsep Secreted enteric antimicrobial activity localises to the mucus surface layer Gut 57 2008 764 771
59. M.E. Johansson, M. Phillipson, J. Petersson, A. Velcich, L. Holm, and G.C. Hansson The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria Proc Natl Acad Sci U S A 105 2008 15064 15069
60. M.E. Johansson, J.M. Larsson, and G.C. Hansson The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions Proc Natl Acad Sci U S A 108 2011 4659 4665
61. K.A. Kline, S. Falker, S. Dahlberg, S. Normark, and B. Henriques-Normark Bacterial adhesins in host-microbe interactions Cell Host Microbe 5 2009 580 592
62. J.S. Bajaj, P.B. Hylemon, J.M. Ridlon, D.M. Heuman, K. Daita, and M.B. White Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation Am J Physiol Gastrointest Liver Physiol 303 2012 G675 G685
63. P. Hartmann, P. Chen, H.J. Wang, L. Wang, D.F. McCole, and K. Brandl Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice Hepatology 58 2013 108 119
64. A. Nishida, C.W. Lau, M. Zhang, A. Andoh, H.N. Shi, and E. Mizoguchi The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice Gastroenterology 142 2012 865 874
65. D.E. Fouts, M. Torralba, K.E. Nelson, D.A. Brenner, and B. Schnabl Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease J Hepatol 56 2012 1283 1292
66. A.C. Levi, F. Borghi, R. Petrino, A. Bargoni, C.M. Fronticelli, and S. Gentelini Modifications of the trophism of intestinal mucosa after intestinal and bilio-pancreatic diversion in the rat Ital J Gastroenterol 23 1991 202 207
67. C.L. Wells, R.P. Jechorek, and S.L. Erlandsen Inhibitory effect of bile on bacterial invasion of enterocytes: possible mechanism for increased translocation associated with obstructive jaundice Crit Care Med 23 1995 301 307
68. L. Bertok Physico-chemical defense of vertebrate organisms: the role of bile acids in defense against bacterial endotoxins Perspect Biol Med 21 1977 70 76
69. H. Van Bossuyt, C. Desmaretz, G.B. Gaeta, and E. Wisse The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat J Hepatol 10 1990 274 279
70. E. Jaensson-Gyllenbeck, K. Kotarsky, F. Zapata, E.K. Persson, T.E. Gundersen, and R. Blomhoff Bile retinoids imprint intestinal CD103+ dendritic cells with the ability to generate gut-tropic T cells Mucosal immunol 4 2011 438 447
71. W.D. Clements, R. Parks, P. Erwin, M.I. Halliday, J. Barr, and B.J. Rowlands Role of the gut in the pathophysiology of extrahepatic biliary obstruction Gut 39 1996 587 593
72. R.W. Parks, W.D. Clements, M.G. Smye, C. Pope, B.J. Rowlands, and T. Diamond Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage Br J Surg 83 1996 1345 1349
73. J.V. Reynolds, P. Murchan, N. Leonard, P. Clarke, F.B. Keane, and W.A. Tanner Gut barrier failure in experimental obstructive jaundice J Surg Res 62 1996 11 16
74. V. Lorenzo-Zuniga, R. Bartoli, R. Planas, A.F. Hofmann, B. Vinado, and L.R. Hagey Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats Hepatology 37 2003 551 557
75. R.M. Gadaleta, K.J. van Erpecum, B. Oldenburg, E.C. Willemsen, W. Renooij, and S. Murzilli Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Gut 60 2011 463 472
76. T. Inagaki, A. Moschetta, Y.K. Lee, L. Peng, G. Zhao, and M. Downes Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor Proc Natl Acad Sci U S A 103 2006 3920 3925
77. G. Spaeth, T. Gottwald, R.D. Specian, M.R. Mainous, R.D. Berg, and E.A. Deitch Secretory immunoglobulin A, intestinal mucin, and mucosal permeability in nutritionally induced bacterial translocation in rats Ann Surg 220 1994 798 808
78. G.R. Harriman, M. Bogue, P. Rogers, M. Finegold, S. Pacheco, and A. Bradley Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes J Immunol 162 1999 2521 2529
79. S.R. Gill, M. Pop, R.T. Deboy, P.B. Eckburg, P.J. Turnbaugh, and B.S. Samuel Metagenomic analysis of the human distal gut microbiome Science 312 2006 1355 1359
80. P. Marteau, P. Pochart, J. Dore, C. Bera-Maillet, A. Bernalier, and G. Corthier Comparative study of bacterial groups within the human cecal and fecal microbiota Appl Environ Microbiol 67 2001 4939 4942
81. G.R. Corazza, M.G. Menozzi, A. Strocchi, L. Rasciti, D. Vaira, and R. Lecchini The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing Gastroenterology 98 1990 302 309
82. J. Chesta, M. Silva, L. Thompson, E. del Canto, and C. Defilippi Bacterial overgrowth in small intestine in patients with liver cirrhosis Rev Med Chil 119 1991 626 632
83. T.M. Bauer, B. Steinbruckner, F.E. Brinkmann, A.K. Ditzen, H. Schwacha, and J.J. Aponte Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis Am J Gastroenterol 96 2001 2962 2967
84. T.M. Bauer, H. Schwacha, B. Steinbrückner, F.E. Brinkmann, A.K. Ditzen, and J.J. Aponte Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia Am J Gastroenterol 97 2002 2364 2370
85. J.C. Bode, C. Bode, R. Heidelbach, H.K. Durr, and G.A. Martini Jejunal microflora in patients with chronic alcohol abuse Hepatogastroenterology 31 1984 30 34
86. A. Pardo, R. Bartoli, V. Lorenzo-Zuniga, R. Planas, B. Vinado, and J. Riba Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis Hepatology 31 2000 858 863
87. F.C. Morencos, C.G. Las Heras, R.L. Martin, M.J. Lopez Arias, F. Ledesma, and R.F. Pons Small bowel bacterial overgrowth in patients with alcoholic cirrhosis Dig Dis Sci 40 1995 1252 1256
88. C.Y. Yang, C.S. Chang, and G.H. Chen Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests Scand J Gastroenterol 33 1998 867 871
89. C.S. Chang, S.S. Yang, C.H. Kao, H.Z. Yeh, and G.H. Chen Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis Scand J Gastroenterol 36 2001 92 96
90. D.W. Jun, K.T. Kim, O.Y. Lee, J.D. Chae, B.K. Son, and S.H. Kim Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients Dig Dis Sci 55 2010 1465 1471
91. C. Guarner, B.A. Runyon, S. Young, M. Heck, and M.Y. Sheikh Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites J Hepatol 26 1997 1372 1378
92. M. Perez-Paramo, J. Munoz, A. Albillos, I. Freile, F. Portero, and M. Santos Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites Hepatology 31 2000 43 48
93. E.K. Steffen, and R.D. Berg Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes Infect Immun 39 1983 1252 1259
94. C.S. Chang, G.H. Chen, H.C. Lien, and H.Z. Yeh Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis Hepatology 28 1998 1187 1190
95. J. Chesta, C. Defilippi, and C. Defilippi Abnormalities in proximal small bowel motility in patients with cirrhosis Hepatology 17 1993 828 832
96. R. Sadik, H. Abrahamsson, E. Björnsson, A. Gunnarsdottir, and P.O. Stotzer Etiology of portal hypertension may influence gastrointestinal transit time Scand J Gastroenterol 38 2003 1039 1044
97. J.J. Stewart, H.D. Battarbee, G.E. Farrar, and K.W. Betzing Intestinal myoelectrical activity and transit time in chronic portal hypertension Am J Physiol 263 1992 G474 G479
98. M. Fried, H. Siegrist, R. Frei, F. Froehlich, P. Duroux, and J. Thorens Duodenal bacterial overgrowth during treatment in outpatients with omeprazole Gut 35 1994 23 26
99. J.S. Bajaj, Y. Zadvornova, D.M. Heuman, M. Hafeezullah, R.G. Hoffmann, and A.J. Sanyal Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites Am J Gastroenterol 104 2009 1130 1134
100. J.S. Bajaj, S.M. Ratliff, D.M. Heuman, and K.L. Lapane Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis Aliment Pharmacol Ther 36 2012 866 874
101. R. Terg, P. Casciato, C. Garbe, M. Cartier, T.E. Stieben, and M. Mendizabal Proton pump inhibitor therapy does not increase the incidence of bacterial infection in decompensated cirrhotic patients. A nationwide multicenter, prospective study Hepatology 56 2013 255A
102. K. Shindo, M. Machida, K. Miyakawa, and M. Fukumura A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption Am J Gastroenterol 88 1993 2084 2091
103. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 486 2012 207 214
104. P.B. Eckburg, E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, and M. Sargent Diversity of the human intestinal microbial flora Science 308 2005 1635 1638
105. Y. Chen, F. Yang, H. Lu, B. Wang, Y. Chen, and D. Lei Characterization of fecal microbial communities in patients with liver cirrhosis Hepatology 54 2011 562 572
106. 4-induced fibrosis PLoS One 6 2011 e23037
107. F. Fava, and S. Danese Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 17 2011 557 566
108. J.C. Arthur, E. Perez-Chanona, M. Muhlbauer, S. Tomkovich, J.M. Uronis, and T.J. Fan Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 2012 120 123
109. C.L. Wells Colonization and translocation of intestinal bacterial flora Transplant Proc 28 1996 2653 2656 [Review]
110. E.K. Steffen, R.D. Berg, and E.A. Deitch Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node J Infect Dis 157 1988 1032 1038
111. C.L. Wells, M.A. Maddaus, C.M. Reynolds, R.P. Jechorek, and R.L. Simmons Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria Infect Immun 55 1987 2689 2694
112. R. Wiest, and H.C. Rath Bacterial translocation in the gut Best Pract Res Clin Gastroenterol 17 2003 397 425
113. F. Bert, J.R. Johnson, B. Ouattara, V. Leflon-Guibout, B. Johnston, and E. Marcon Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis J Clin Microbiol 48 2010 2709 2714
114. G. Garcia-Tsao Spontaneous bacterial peritonitis Gastroenterol Clin North Am 21 1991 257 275
115. M. Navasa, A. Follo, J.M. Llovet, G. Clemente, V. Vargas, and A. Rimola Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis Gastroenterology 111 1996 1011 1017 [See comments]
116. W.E. Fleig, W. Grothe, E. Lotterer, and S. Behl Spontaneous bacterial peritonitis (SBP). Retrospective and prospective data from a multicenter study on prevalence, diagnosis and therapy in Germany Dtsch Med Wochenschr 20 2004 1792 1797
117. M. Katouli, C.G. Nettebladt, V. Muratov, O. Ljungqvist, T. Bark, and T. Svenberg Selective translocation of coliform bacteria adhering to caecal epithelium of rats during catabolic stress J Med Microbiol 46 1997 571 578
118. C.L. Wells Relationship between intestinal microecology and the translocation of intestinal bacteria Antonie Van Leeuwenhoek 58 1990 87 93 [Review]
119. M. Ljungdahl, M. Lundholm, M. Katouli, I. Rasmussen, L. Engstrand, and U. Haglund Bacterial translocation in experimental shock is dependent on the strains in the intestinal flora Scand J Gastroenterol 35 2000 389 397
120. C.T. Taylor, A.L. Dzus, and S.P. Colgan Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha Gastroenterology 114 1998 657 668
121. R. Frances, M. Chiva, E. Sanchez, J.M. Gonzalez-Navajas, T. Llovet, and P. Zapater Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites J Hepatol 46 2007 797 803
122. F. Corradi, C. Brusasco, J. Fernandez, J. Vila, M.J. Ramirez, and T. Seva-Pereira Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites Dig Liver Dis 44 2012 239 244
123. E. Gabele, M. Muhlbauer, H. Paulo, M. Johann, C. Meltzer, and F. Leidl Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis World J Gastroenterol 15 2009 5558 5562
124. J. Genesca, R. Marti, F. Rojo, F. Campos, V. Peribanez, and A. Gonzalez Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites Gut 52 2003 1054 1059
125. L. Munoz, A. Albillos, M. Nieto, E. Reyes, L. Lledo, and J. Monserrat Mesenteric Th1 polarization and monocyte TNF-alpha production: first steps to systemic inflammation in rats with cirrhosis Hepatology 42 2005 411 419
126. A. Albillos, A. de la Hera, E. Reyes, J. Monserrat, L. Munoz, and M. Nieto Tumor necrosis factor-alpha expression by activated monocytes and altered T cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin J Hepatol 40 2004 624 631
127. T. Suzuki, N. Yoshinaga, and S. Tanabe Interleukin-6 (IL-6] regulates claudin-2 expression and tight junction permeability in intestinal epithelium J Biol Chem 286 2011 31263 31271
128. E. Clark, C. Hoare, J. Tanianis-Hughes, G.L. Carlson, and G. Warhurst Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process Gastroenterology 128 2005 1258 1267
129. F.Y. Lee, R.H. Lu, Y.T. Tsai, H.C. Lin, M.C. Hou, and C.P. Li Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation Scand J Gastroenterol 31 1996 500 505
130. N.G. Sandler, C. Koh, A. Roque, J.L. Eccleston, R.B. Siegel, and M. Demino Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection Gastroenterology 141 2011 1220 1230
131. R. Wiest, J. Weigert, J. Wanninger, M. Neumeier, S. Bauer, and S. Schmidhofer Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis Cytokine 53 2011 178 183
132. J. Deviere, J. Content, C. Denys, P. Vandenbussche, L. Schandene, and J. Wybran Excessive in vitro bacterial lipopolysaccharide-induced production on monokines in cirrhosis Hepatology 11 1990 628 634
133. R. Frances, C. Munoz, P. Zapater, F. Uceda, I. Gascon, and S. Pascual Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites Gut 53 2004 860 864
134. R. Frances, E. Rodriguez, C. Munoz, P. Zapater, M.L. De la, and M. Ndongo Intracellular cytokine expression in peritoneal monocyte/macrophages obtained from patients with cirrhosis and presence of bacterial DNA Eur J Gastroenterol Hepatol 17 2005 45 51
135. K.A. Tazi, J.J. Quioc, V. Saada, A. Bezeaud, D. Lebrec, and R. Moreau Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M J Hepatol 45 2006 280 289
136. I. Schoultz, C.M. McKay, R. Graepel, V.C. Phan, A. Wang, and J. Soderholm Indomethacin-induced translocation of bacteria across enteric epithelia is reactive oxygen species-dependent and reduced by vitamin C Am J Physiol Gastrointest Liver Physiol 303 2012 G536 G545
137. S.M. Ivison, C. Wang, M.E. Himmel, J. Sheridan, J. Delano, and M.L. Mayer Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin Am J Physiol Gastrointest Liver Physiol 299 2010 G733 G741
138. R. Prabhu, and K.A. Balasubramanian Altered glycosylation of surfactant and brush border membrane of the small intestine in response to surgical manipulation J Surg Res 117 2004 272 282
139. A. Ramachandran, R. Prabhu, S. Thomas, J.B. Reddy, A. Pulimood, and K.A. Balasubramanian Intestinal mucosal alterations in experimental cirrhosis in the rat: role of oxygen free radicals Hepatology 35 2002 622 629
140. M. Chiva, C. Guarner, C. Peralta, T. Llovet, G. Gomez, and G. Soriano Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats Eur J Gastroenterol Hepatol 15 2003 145 150
141. F. Obermeier, V. Gross, J. Scholmerich, and W. Falk Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide J Leukoc Biol 66 1999 829 836
142. J.L. Wallace, and M.J. Miller Nitric oxide in mucosal defense: a little goes a long way Gastroenterology 119 2000 512 520
143. I. Alican, and P. Kubes A critical role for nitric oxide in intestinal barrier function and dysfunction Am J Physiol 270 1996 G225 G237
144. R. Wiest, and R.J. Groszmann Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance Semin Liver Dis 19 1999 411 426
145. J. Lopez-Belmonte, B.J. Whittle, and S. Moncada The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa Br J Pharmacol 108 1993 73 78
146. B.L. Tepperman, J.F. Brown, and B.J. Whittle Nitric oxide synthase induction and intestinal epithelial cell viability in rats Am J Physiol 265 1993 G214 G218
147. R.M. Forsythe, D.Z. Xu, Q. Lu, and E.A. Deitch Lipopolysaccharide-induced enterocyte-derived nitric oxide induces intestinal monolayer permeability in an autocrine fashion Shock 17 2002 180 184
148. A.L. Salzman, M.J. Menconi, N. Unno, R.M. Ezzell, D.M. Casey, and P.K. Gonzalez Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers Am J Physiol 268 1995 G361 G373
149. N. Unno, H. Wang, M.J. Menconi, S.H. Tytgat, V. Larkin, and M. Smith Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats Gastroenterology 113 1997 1246 1257
150. L.W. Chen, C.M. Hsu, J.S. Wang, J.S. Chen, and S.C. Chen Specific inhibition of iNOS decreases the intestinal mucosal peroxynitrite level and improves the barrier function after thermal injury Burns 24 1998 699 705
151. J. Du Plessis, H. Vanheel, C.E. Janssen, L. Roos, and T. Slavik Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function J Hepatol 58 2013 1125 1132
152. S. Mishima, D. Xu, Q. Lu, and E.A. Deitch Bacterial translocation is inhibited in inducible nitric oxide synthase knockout mice after endotoxin challenge but not in a model of bacterial overgrowth Arch Surg 132 1997 1190 1195
153. A.V. Keita, and J.D. Soderholm The intestinal barrier and its regulation by neuroimmune factors Neurogastroenterol Motil 22 2010 718 733
154. M. Worlicek, K. Knebel, H.J. Linde, L. Moleda, J. Scholmerich, and R.H. Straub Splanchnic sympathectomy prevents translocation and spreading of E. coli but not S aureus in liver cirrhosis Gut 59 2010 1127 1134
155. P.P. Freestone, P.H. Williams, R.D. Haigh, A.F. Maggs, C.P. Neal, and M. Lyte Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis Shock 18 2002 465 470
156. M. Senzolo, E. Cholongitas, P. Burra, G. Leandro, U. Thalheimer, and D. Patch Beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis Liver Int 29 2009 1189 1193
157. L.V. Borovikova, S. Ivanova, M. Zhang, H. Yang, G.I. Botchkina, and L.R. Watkins Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Nature 405 2000 458 462
158. W.J. de Jonge, E.P. van der Zanden, F.O. The, M.F. Bijlsma, D.J. van Westerloo, and R.J. Bennink Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway Nat Immunol 6 2005 844 851
159. T.W. Costantini, V. Bansal, M. Krzyzaniak, J.G. Putnam, C.Y. Peterson, and W.H. Loomis Vagal nerve stimulation protects against burn-induced intestinal injury through activation of enteric glia cells Am J Physiol Gastrointest Liver Physiol 299 2010 G1308 G1318
160. F. Sanchez-Patan, R. Anchuelo, E. Vara, C. Garcia, Y. Saavedra, and P. Vergara Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids Hepatobiliary Pancreat Dis Int 7 2008 383 394
161. C.M. Hodin, K. Lenaerts, J. Grootjans, J.J. de Haan, M. Hadfoune, and F.K. Verheyen Starvation compromises Paneth cells Am J Pathol 179 2011 2885 2893
162. A. Nazli, P.C. Yang, J. Jury, K. Howe, J.L. Watson, and J.D. Soderholm Epithelia under metabolic stress perceive commensal bacteria as a threat Am J Pathol 164 2004 947 957
163. K. Cheung, S.S. Lee, and M. Raman Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies Clin Gastroenterol Hepatol 10 2012 117 125
164. F. Casafont, E. Sanchez, L. Martin, J. Aguero, and F.P. Romero Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats Hepatology 25 1997 1334 1337
165. S. Lala, Y. Ogura, C. Osborne, S.Y. Hor, A. Bromfield, and S. Davies Crohn's disease and the NOD2 gene: a role for paneth cells Gastroenterology 125 2003 47 57
166. J.P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, and J. Belaiche Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
167. Y. Ogura, D.K. Bonen, N. Inohara, D.L. Nicolae, and F.F. Chen A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 2001 603 606
168. E. Holler, G. Rogler, H. Herfarth, J. Brenmoehl, P.J. Wild, and J. Hahn Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation Blood 104 2004 889 894
169. T. Bruns, J. Peter, S. Hagel, R. Pfeifer, P. Prinz, and A. Stallmach Homozygous carrier of the NOD2 1007fs frame-shift mutation presenting with refractory community-acquired spontaneous bacterial peritonitis and developing fatal pulmonary mucormycosis: a case report Hepatol Res 41 2011 1009 1014
170. T. Bruns, J. Peter, P.A. Reuken, D.H. Grabe, S.R. Schuldes, and J. Brenmoehl NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis Liver Int 32 2012 223 230
171. B. Appenrodt, F. Grunhage, M.G. Gentemann, L. Thyssen, T. Sauerbruch, and F. Lammert Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis Hepatology 51 2010 1327 1333
172. K.S. Kobayashi, M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, and G. Nunez Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 307 2005 731 734
173. C.L. Bevins, E.F. Stange, and J. Wehkamp Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype Gut 58 2009 882 883
174. T. Petnicki-Ocwieja, T. Hrncir, Y.J. Liu, A. Biswas, T. Hudcovic, and H. Tlaskalova-Hogenova Nod2 is required for the regulation of commensal microbiota in the intestine Proc Natl Acad Sci U S A 106 2009 15813 15818
175. L.H. Travassos, L.A. Carneiro, M. Ramjeet, S. Hussey, Y.G. Kim, and J.G. Magalhaes Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry Nat Immunol 11 2010 55 62
176. H.D. Nischalke, C. Berger, K. Aldenhoff, L. Thyssen, M. Gentemann, and F. Grunhage Toll-like receptor (TLR) 2 promotor and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis J Hepatol 55 2011 1010 1016
177. S.J. Bielinski, J.L. Hall, J.S. Pankow, E. Boerwinkle, N. Matijevic-Aleksic, and M. He Genetic variants in TLR2 and TLR4 are associated with markers of monocyte activation: the Atherosclerosis Risk in Communities MRI Study Hum Genet 129 2011 655 662
178. M.G. Netea, G. Ferwerda, D.J. de Jong, T. Jansen, L. Jacobs, and M. Kramer Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release J Immunol 174 2005 6518 6523
179. S.E. Girardin, D.J. Philpott, and B. Lemaitre Sensing microbes by diverse hosts. Workshop on pattern recognition proteins and receptors EMBO Rep 4 2003 932 936
180. M.E. Borm, A.A. van Bodegraven, C.J. Mulder, G. Kraal, and G. Bouma The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype Genes Immun 9 2008 274 278
181. B. Foligne, G. Zoumpopoulou, J. Dewulf, A. Ben Younes, F. Chareyre, and J.C. Sirard A key role of dendritic cells in probiotic functionality PLoS One 2 2007 e313
182. R. Wiest, S. Das, G. Cadelina, G. Garcia-Tsao, S. Milstien, and R.J. Groszmann Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility J Clin Invest 104 1999 1223 1233
183. A. Albillos, A. DelaHera, M. Gonzalez, J. Moya, J. Calleja, and J. Monserrat Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement Hepatology 37 2003 208 217
184. E. Kalaitzakis, J.E. Johansson, I. Bjarnason, and E. Bjornsson Intestinal permeability in cirrhotic patients with and without ascites Scand J Gastroenterol 41 2006 326 330
185. J.H. Henriksen, S. Moller, H. Ring-Larsen, and N.J. Christensen The sympathetic nervous system in liver disease J Hepatol 29 1998 328 341
186. J. Sam, and G.C. Nguyen Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension Liver Int 29 2009 1396 1402
187. M. Andreu, R. Sola, A. Sitges-Serra, C. Alia, M. Gallen, and M.C. Vila Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites Gastroenterology 104 1993 1133 1138
188. C. Guarner, R. Sola, G. Soriano, M. Andreu, M.T. Novella, and M.C. Vila Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels Gastroenterology 117 1999 414 419
189. P. Tandon, and G. Garcia-Tsao Bacterial infections, sepsis, and multiorgan failure in cirrhosis Semin Liver Dis 28 2008 26 42
190. G. Garcia-Tsao, A. Albillos, G.E. Barden, and A.B. West Bacterial translocation in acute and chronic portal hypertension Hepatology 17 1993 1081 1085 [See comments]
191. F.B. Kasravi, L. Wang, X.D. Wang, G. Molin, S. Bengmark, and B. Jeppsson Bacterial translocation in acute liver injury induced by D-galactosamine Hepatology 23 1996 97 103
192. C. Pande, A. Kumar, and S.K. Sarin Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease Aliment Pharmacol Ther 29 2009 1273 1281
193. C.C. Chan, S.J. Hwang, F.Y. Lee, S.S. Wang, F.Y. Chang, and C.P. Li Prognostic value of plasma endotoxin levels in patients with cirrhosis Scand J Gastroenterol 32 1997 942 946
194. R.S. Lin, F.Y. Lee, S.D. Lee, Y.T. Tsai, H.C. Lin, and R.H. Lu Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation J Hepatol 22 1995 165 172
195. I. Cirera, T.M. Bauer, M. Navasa, J. Vila, L. Grande, and P. Taura Bacterial translocation of enteric organisms in patients with cirrhosis J Hepatol 34 2001 32 37
196. M. Ubeda, L. Munoz, M.J. Borrero, D. Diaz, R. Frances, and J. Monserrat Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis Hepatology 52 2010 2086 2095
197. L.M. Bigatello, S.A. Broitman, L. Fattori, M. DiPaoli, M. Pontello, and G. Bevilacqua Endotoxemia, encephalopathy, and mortality in cirrhotic patients Am J Gastroenterol 82 1987 11 15
198. J. Such, R. Frances, C. Munoz, P. Zapater, J.A. Casellas, and A. Cifuentes Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites Hepatology 36 2002 135 141
199. J.W. Baker, E.A. Deitch, M. Li, R.D. Berg, and R.D. Specian Hemorrhagic shock induces bacterial translocation from the gut J Trauma 28 1988 896 906
200. W.T. Sorell, E.M. Quigley, G. Jin, T.J. Johnson, and L.F. Rikkers Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock Gastroenterology 104 1993 1722 1726
201. M.D. Luyer, W.A. Buurman, M. Hadfoune, T. Wolfs, C. Van't Veer, and J.A. Jacobs Exposure to bacterial DNA before hemorrhagic shock strongly aggravates systemic inflammation and gut barrier loss via an IFN-gamma-dependent route Ann Surg 245 2007 795 802
202. B.I. Kim, H.J. Kim, J.H. Park, D.I. Park, Y.K. Cho, and C.I. Sohn Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage J Gastroenterol Hepatol 26 2011 550 557
203. J.T. Sambol, D.Z. Xu, C.A. Adams, L.J. Magnotti, and E.A. Deitch Mesenteric lymph duct ligation provides long term protection against hemorrhagic shock-induced lung injury Shock 14 2000 416 419
204. M.R. Mainous, P. Tso, R.D. Berg, and E.A. Deitch Studies of the route, magnitude, and time course of bacterial translocation in a model of systemic inflammation Arch Surg 126 1991 33 37
205. J.M. Llovet, R. Bartoli, R. Planas, E. Cabre, M. Jimenez, and A. Urban Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis Gut 35 1994 1648 1652
206. D.W. Powell Barrier function of epithelia Am J Physiol 241 1981 G275 G288
207. I.H. Koh, R. Guatelli, E.F. Montero, R. Keller, M.H. Silva, and S. Goldenberg Where is the site of bacterial translocation-small or large bowel? Transplant Proc 28 1996 2661
208. J. MacFie, C. O'Boyle, C.J. Mitchell, P.M. Buckley, D. Johnstone, and P. Sudworth Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity Gut 45 1999 223 228
209. J.C. Marshall, N.V. Christou, R. Horn, and J.L. Meakins The microbiology of multiple organ failure. The proximal gastrointestinal tract as an occult reservoir of pathogens Arch Surg 123 1988 309 315